Home - Products - Vancomycin hydrochloride - Taizhou

Vancomycin hydrochloride

(manufactured in Taizhou, China)

Vancomycin hydrochloride is a glycopeptide antibiotic active against a wide variety of Gram-positive bacteria, most important being staphylococci, including Staphylococcus aureus and Staphylococcus epidermidis (including heterogeneous methicillin-resistant strains), but also active against diphtheroids, enterococci, (e.g. Enterococcus faecalis), Streptococcus bovis and viridans group streptococci.

Indication: Used in the treatment of severe systemic methicillin resistant (MRSA) and sensitive strains where other antibiotics cannot be used due to intolerance or drug resistance. May be administered orally for treating antibiotic-associated pseudomembranous colitis produced by Clostridium difficile and for staphylococcal enterocolitis.

Application: Administered systemically as intravenous infusions and as capsules for oral administration. IV form can also be used orally for the treatment of Clostridium difficile infections.

Product grades

Non-sterile, non-micronized

Compliance

Ph. Eur.

USP

Manufacturing site

Xellia (Taizhou) Pharmaceuticals Co., Ltd., China

Release site

Xellia (Taizhou) Pharmaceuticals Co., Ltd., China

Site registered

EU GMP issued by Danish Medicines Agency

US FDA

Regulatory documentation

EU Drug Master File (DMF)/Certificate of Suitability (CEP)

US Drug Master File (DMF)

Letter of Access (LoA)

Packaging sizes

2.5 kg

8 kg

10 kg

Packaging material

Primary: Aluminum foil bag (double sealed)

Secondary: Plastic cardboard box

Shelf life

2 years (according to Ph. Eur.)

3 years (according to USP)

Storage conditions

Below 8°C (46°F)

Other documentations

Written confirmation for import into EU
Chinese Manufacturing License (Taizhou Site)